Date | Subject |
---|---|
2023-01-25 03:47:33 | SAVA gain ***** |
2023-01-24 00:04:52 | Cassava Sciences (SAVA) Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer s Disease |
2023-01-20 01:13:12 | $SAVA (Cassava Sciences) Alzheimer's Drug Full DD |